- Home
- IKT vs ALPP Comparison
IKT vs ALPP Comparison
Compare IKT & ALPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- ALPP
- Stock Information
- Founded
- IKT 2008
- ALPP 2014
- Country
- IKT United States
- ALPP United States
- Employees
- IKT N/A
- ALPP N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- ALPP Telecommunications Equipment
- Sector
- IKT Health Care
- ALPP Telecommunications
- Exchange
- IKT Nasdaq
- ALPP Nasdaq
- Market Cap
- IKT 13.4M
- ALPP 10.6M
- IPO Year
- IKT 2020
- ALPP N/A
- Fundamental
- Price
- IKT $1.34
- ALPP $0.38
- Analyst Decision
- IKT Strong Buy
- ALPP
- Analyst Count
- IKT 1
- ALPP 0
- Target Price
- IKT $15.00
- ALPP N/A
- AVG Volume (30 Days)
- IKT 20.2K
- ALPP 33.2K
- Earning Date
- IKT 08-14-2024
- ALPP 09-13-2024
- Dividend Yield
- IKT N/A
- ALPP N/A
- EPS Growth
- IKT N/A
- ALPP N/A
- EPS
- IKT N/A
- ALPP N/A
- Revenue
- IKT $79,570.00
- ALPP $104,197,850.00
- Revenue This Year
- IKT N/A
- ALPP $9.50
- Revenue Next Year
- IKT N/A
- ALPP N/A
- P/E Ratio
- IKT N/A
- ALPP N/A
- Revenue Growth
- IKT N/A
- ALPP 15.71
- 52 Week Low
- IKT $0.79
- ALPP $0.31
- 52 Week High
- IKT $3.82
- ALPP $1.30
- Technical
- Relative Strength Index (RSI)
- IKT 46.33
- ALPP 41.17
- Support Level
- IKT $1.27
- ALPP $0.38
- Resistance Level
- IKT $1.43
- ALPP $0.44
- Average True Range (ATR)
- IKT 0.13
- ALPP 0.04
- MACD
- IKT 0.00
- ALPP -0.00
- Stochastic Oscillator
- IKT 37.50
- ALPP 25.20
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About ALPP Alpine 4 Holdings Inc.
Alpine 4 Holdings Inc is a holding company that acquires businesses in several industry segments namely Aerospace, Battery Tech, Defense Services, Technology, and Manufacturing, as either a Driver, Stabilizer, or Facilitator from the company's disruptive DSF business model. It focuses on how the incorporation of new technologies can drive innovation even in brick-and-mortar businesses, with an understanding of how technology and innovation can enhance businesses.